FIXX stock forecast
Our latest prediction for Homology Medicines, Inc.'s stock price was made on the Jan. 30, 2020 when the stock price was at 15.99$.
In the short term (2weeks), FIXX's stock price should underperform the market by -3.04%. During that period the price should oscillate between -11.89% and +10.42%.
In the medium term (3months), FIXX's stock price should underperform the market by -6.25%. During that period the price should oscillate between -38.52% and +27.45%.Get email alerts
About Homology Medicines, Inc.
Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -2.50$ per share.
The book value per share is 6.05$
Three months stock forecastJan. 30, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|